Aspen Clinical Research is currently enrolling qualified applicants into a clinical research study for those who have been diagnosed with Multiple Sclerosis. Participants in this study will receive an oral investigational medication (medication not FDA approved) or a oral comparator medication (FDA approved medication) to help determine whether the investigational medication is more effective in reducing relapses of Multiple Sclerosis than the comparator medication. No placebo will be used in this clinical research study.
Your first visit to the research clinic will be a screening visit. During this visit you will meet with a study coordinator to fully review study details. If you decide to participate, a more in depth assessment of your health will take place to determine your final eligibility. If you are eligible and choose to enroll, you will be required to return to our research clinic various times for treatment and follow-up visits.
Space in the study is limited. Health insurance is not required. All clinical visits, medications, and physical exams are provided at no cost to you. Those who qualify and participate in this clinical research study may receive reimbursement for time and travel.
For more in-depth information regarding this study please click HERE.
Please complete the information below to see if you pre-qualify for the study.
Disclaimer: Not all individuals that complete the on-line questionnaire will qualify for the study. An in-depth study and medical evaluation must be completed in person in order to qualify for the study.